Steven Cohen’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ABCL
BBA
Steven Cohen's ABCL Position: Q3 2026 in Review
Steven Cohen opened a new position in AbCellera Biologics (ABCL) in Q3 2026: 136,181 shares worth $1.99M. The stake represents ﹤0.01% of the portfolio and ranks #2423 among its holdings. This is a return to the name: Steven Cohen previously reported a position in ABCL as recently as Q1 2026.
Steven Cohen first reported a position in ABCL in Q4 2020 and has held it in 6 quarters since. The position peaked at $5.47M in Q3 2021. 163 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.
- Steven Cohen held 136,181 shares of AbCellera Biologics worth $1.99M as of Q3 2026.
- AbCellera Biologics was a new Steven Cohen position in Q3 2026.
- AbCellera Biologics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2423 holding.
- Steven Cohen first reported a position in AbCellera Biologics in Q4 2020 and has held it in 6 quarters since.
- Steven Cohen's AbCellera Biologics position peaked at $5.47M in Q3 2021.
- 163 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.